Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗
Director Danziger buys 10,000 shares of ALTS at $7.30; price now $2.89, down 71.8% from 52-week high.
Director David C. Danziger doubled his shareholding by purchasing 10,000 shares at $7.30 on 2025-08-14, increasing his position from 10,000 to 20,000 shares for a total of $73,000. However, the current stock price has deteriorated significantly to $2.89, representing a 71.8% decline from the 52-week high of $10.26 and a 27.9% drop over the past 30 days. The company is unprofitable, posting a net loss of $9.1M on quarterly revenue of $6.4M. The timing of this purchase—at $7.30—is notably unfavorable in retrospect given the sharp subsequent price decline, raising questions about visibility or conviction relative to near-term deteriorating fundamentals.
CFO Johnson Virland A buys 3.0K shares of ALTS at $3.00 (initial stake); stock near 52-week high, company unprofitable with -100.0% annual revenue growth.
Johnson Virland A, CFO of ALT5 Sigma Corp, purchased 3,000 shares at $3.00 on 2024-12-06, representing his first shareholding in the company. The purchase occurred near the stock's 52-week high of $3.33, following a 30-day rally of +32.7% and 90-day gain of +43.5%. However, the company's fundamentals present significant headwinds: it generated $4.9M in quarterly revenue but reported a net loss of $-822.0K, and full-year annual revenue growth was -100.0%, indicating a material contraction. The CFO's initial position purchase at elevated valuations during a period of negative profitability and sharp revenue decline warrants monitoring, as it occurs amid deteriorating operational metrics rather than improving conditions.
CEO Tassiopoulos bought 5,000 shares at $2.06; stock now $2.32 on distressed fundamentals.
CEO Tassiopoulos purchased 5,000 shares at $2.06 on 2024-09-09, increasing his holdings from 415,000 to 420,000 shares. The transaction occurred in a context of significant financial deterioration: the company reported annual revenue growth of -100.0% and was unprofitable over its most recent full fiscal year, despite recent quarterly revenue of $2.2M and net income of $589.0K. The stock traded at $2.06 at time of purchase and currently trades at $2.32, which is -20.6% from its 52-week high of $2.92. The purchase represents a modest addition (+1.2% vs pre-transaction holdings) to an already substantial position, making the transaction difficult to characterize as a conviction-driven accumulation given the scale of operational headwinds evident in the fundamentals.
Add AIFC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
